Local anaesthetic wound infiltration in addition to standard anaesthetic regimen in total hip and knee replacement: Long-term cost-effectiveness analyses alongside the APEX randomised controlled trials

BMC Medicine

Volumn 13, Issue 1, 2015, Pages

  Marques, Elsa M R ^a   Blom, Ashley W ^a   Lenguerrand, Erik ^a   Wylde, Vikki ^a   Noble, Sian M ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Cost effectiveness; Cost utility; Local anaesthetic wound infiltration; Total hip replacement; Total knee replacement; Trial based economic evaluation

Indexed keywords

ARTICLE; BOOTSTRAPPING; COST CONTROL; COST EFFECTIVENESS ANALYSIS; FEMORAL NERVE; FOLLOW UP; HEALTH CARE UTILIZATION; HIP ARTHROPLASTY; HIP OSTEOARTHRITIS; HUMAN; KNEE OSTEOARTHRITIS; LOCAL ANESTHESIA; LOCAL ANESTHETIC WOUND INFILTRATION; MULTICENTER STUDY (TOPIC); NERVE BLOCK; PAIN SEVERITY; QUALITY ADJUSTED LIFE YEAR; RANDOMIZED CONTROLLED TRIAL (TOPIC); SENSITIVITY ANALYSIS; TOTAL KNEE REPLACEMENT; UNITED KINGDOM; WESTERN ONTARIO AND MCMASTER UNIVERSITIES OSTEOARTHRITIS INDEX; ADVERSE EFFECTS; AGED; ANALGESIA; CONTROLLED STUDY; COST BENEFIT ANALYSIS; ECONOMICS; FEMALE; KNEE ARTHROPLASTY; MALE; OUTCOME ASSESSMENT; PAIN, POSTOPERATIVE; PROCEDURES; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; WOUND CLOSURE;

LOCAL ANESTHETIC AGENT;

AGED; ANESTHESIA, LOCAL; ANESTHETICS, LOCAL; ARTHROPLASTY, REPLACEMENT, KNEE; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PAIN MANAGEMENT; PAIN, POSTOPERATIVE; QUALITY-ADJUSTED LIFE YEARS; SURVEYS AND QUESTIONNAIRES; WOUND CLOSURE TECHNIQUES;

EID: 84936083839     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/s12916-015-0389-1     Document Type: Article

References (28)

1. National Joint Registry for England Wales and the Northern Ireland. 11th Annual Report. Hemel Hempstead: NJR Centre. 2014.
2. Centers for Disease Control and Prevention/NCHS. National Hospital Discharge Survey: 2010 table, Procedures by selected patient characteristics - Number by procedure category and age. http://www.cdc.gov/nchs/data/nhds/4procedures/2010pro4_numberprocedureage.pdf . 2010.
3. Beswick AD, Wylde V, Gooberman-Hill R, Blom A, Dieppe P. What proportion of patients report long-term pain after total hip or knee replacement for osteoarthritis? A systematic review of prospective studies in unselected patients. BMJ Open. 2012;2, e000435.
4. Marques EMR, Jones HE, Elvers KT, Pyke M, Blom AW, Beswick AD. Local anaesthetic infiltration for peri-operative pain control in total hip and knee replacement: systematic review and meta-analyses of short- and long-term effectiveness. BMC Musculoskelet Disord. 2014;15:220.
5. Wylde V, Lenguerrand E, Gooberman-Hill R, Beswick AD, Marques E, Noble S, et al. The effect of local anaesthetic infiltration on chronic post-surgical pain after total hip and knee replacement: The APEX randomised controlled trials. Pain. 2015;156(6):1161-70.
6. Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, et al. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. Value Health. 2013;16:e1-5.
7. National Institute for Health and Clinical Excellence. Guide to the methods of technology appraisal 2013. London: NICE; 2013.
8. Wylde V, Gooberman-Hill R, Horwood J, Beswick A, Noble S, Brookes S, et al. The effect of local anaesthetic wound infiltration on chronic pain after lower limb joint replacement: a protocol for a double-blind randomised controlled trial. BMC Musculoskelet Disord. 2011;12:53.
9. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988;15:1833-40.
10. National Institute for Health and Clinical Excellence. Guide to the methods of technology appraisal 2013: Section 6.3 'Decision-Making'. London: NICE; 2013.
11. The EuroQol Group. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199-208.
12. Marques E, Johnson EC, Gooberman-Hill R, Blom AW, Noble S. Using resource use logs to reduce the amount of missing data in economic evaluations alongside trials. Value Health. 2013;16:195-201.
13. Noble S. APEX - Hip replacement participant resource use log: 0 to 3 months. DIRUM; 2012. http://www.dirum.org/instruments/details/54 .
14. Noble S. APEX - 3-month post-operative hip questionnaire. DIRUM; 2012. http://www.dirum.org/instruments/details/55 .
15. Department of Health. NHS reference costs: financial year 2012 to 2013. https://www.gov.uk/government/publications/nhs-reference-costs-2012-to-2013 .
16. Curtis L. Unit costs of health and social care 2013. Personal Social Services Research Unit. Canterbury: University of Kent; 2014.
17. Joint Formulary Committee. British National Formulary. 68th ed. London: BMJ Group and Pharmaceutical Press; 2014.
18. Dolan P, Gudex C, Kind P, Williams A. A social tariff for EuroQol: results from a UK general population survey. Working Papers, vol. 138 chedp. York: University of York, Centre for Health Economics; 1995.
19. Manca A, Hawkins N, Sculpher MJ. Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility. Health Econ. 2005;14:487-96.
20. White IR, Royston P, Wood AM. Multiple imputation using chained equations: Issues and guidance for practice. Stat Med. 2011;30:377-99.
21. Royston P. Multiple imputation of missing values: update. Stata J. 2005;5:188-201.
22. Weinstein MC, Stason WB. Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med. 1977;296:716-21.
23. Hoch JS, Briggs AH, Willan AR. Something old, something new, something borrowed, something blue: a framework for the marriage of health econometrics and cost-effectiveness analysis. Health Econ. 2002;11:415-30.
24. Claxton K, Martin S, Soares M, Rice N, Spackman E, Hinde S, Devlin N, Smith PC, Sculpher M. Methods for the estimation of the NICE cost effectiveness threshold. Health Technology Assessment 2015;19(14):doi10.3310/hta19140.
25. Black WC. The CE, plane: a graphic representation of cost-effectiveness. Med Decis Making. 1990;10:212-4.
26. StataCorp. Stata Statistical Software: Release 13. College Station, TX: StataCorp LP; 2013.
27. Busch CA, Whitehouse MR, Shore BJ, MacDonald SJ, McCalden RW, Bourne RB. The efficacy of periarticular multimodal drug infiltration in total hip arthroplasty. Clin Orthop Relat Res. 2010;468:2152-9.
28. Koh IJ, Kang YG, Chang CB, Do SH, Seong SC, Kim TK. Does periarticular injection have additional pain relieving effects during contemporary multimodal pain control protocols for TKA? A randomised, controlled study. Knee. 2012;19:253-9.